Efficacy of Coronary Calcium Score in Predicting Coronary Artery Morphology in Patients With Obstructive Coronary Artery Disease.

coronary artery disease coronary calcium score coronary computed tomography angiography near-infrared spectroscopy-intravascular ultrasound risk stratification vulnerable plaque

Journal

Journal of the Society for Cardiovascular Angiography & Interventions
ISSN: 2772-9303
Titre abrégé: J Soc Cardiovasc Angiogr Interv
Pays: United States
ID NLM: 9918419271306676

Informations de publication

Date de publication:
Mar 2024
Historique:
received: 02 01 2024
revised: 11 01 2024
accepted: 12 01 2024
medline: 12 8 2024
pubmed: 12 8 2024
entrez: 12 8 2024
Statut: epublish

Résumé

Coronary artery calcium score (CACS) is an established marker of coronary artery disease (CAD) and has been extensively used to stratify risk in asymptomatic individuals. However, the value of CACS in predicting plaque morphology in patients with advanced CAD is less established. The present analysis aims to assess the association between CACS and plaque characteristics detected by near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS) imaging in patients with obstructive CAD. Seventy patients with obstructive CAD underwent coronary computed tomography angiography (CTA) and 3-vessel NIRS-IVUS imaging were included in the present analysis. The CTA data were used to measure the CACS in the entire coronary tree and the segments assessed by NIRS-IVUS, and these estimations were associated with the NIRS-IVUS measurements at a patient and segment level. In total, 65 patients (188 segments) completed the study protocol and were included in the analysis. A weak correlation was noted between the CACS, percent atheroma volume (r = 0.271, In patients with obstructive CAD, the CACS is not associated with the lipid content or plaque phenotypes. These findings indicate that the CACS may have a limited value for screening or stratifying cardiovascular risk in symptomatic patients with a high probability of CAD.

Sections du résumé

Background UNASSIGNED
Coronary artery calcium score (CACS) is an established marker of coronary artery disease (CAD) and has been extensively used to stratify risk in asymptomatic individuals. However, the value of CACS in predicting plaque morphology in patients with advanced CAD is less established. The present analysis aims to assess the association between CACS and plaque characteristics detected by near-infrared spectroscopy-intravascular ultrasound (NIRS-IVUS) imaging in patients with obstructive CAD.
Methods UNASSIGNED
Seventy patients with obstructive CAD underwent coronary computed tomography angiography (CTA) and 3-vessel NIRS-IVUS imaging were included in the present analysis. The CTA data were used to measure the CACS in the entire coronary tree and the segments assessed by NIRS-IVUS, and these estimations were associated with the NIRS-IVUS measurements at a patient and segment level.
Results UNASSIGNED
In total, 65 patients (188 segments) completed the study protocol and were included in the analysis. A weak correlation was noted between the CACS, percent atheroma volume (r = 0.271,
Conclusions UNASSIGNED
In patients with obstructive CAD, the CACS is not associated with the lipid content or plaque phenotypes. These findings indicate that the CACS may have a limited value for screening or stratifying cardiovascular risk in symptomatic patients with a high probability of CAD.

Identifiants

pubmed: 39131224
doi: 10.1016/j.jscai.2024.101308
pii: S2772-9303(24)00015-2
pmc: PMC11307846
doi:

Types de publication

Journal Article

Langues

eng

Pagination

101308

Informations de copyright

© 2024 The Author(s).

Auteurs

Xingwei He (X)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Division of Cardiology, Department of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Soe Maung (S)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.

Anantharaman Ramasamy (A)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Mohamed O Mohamed (MO)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Institute of Health Informatics, University College London, London, United Kingdom.

Retesh Bajaj (R)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Nathan Angelo Lecaros Yap (NAL)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.

Medeni Karaduman (M)

Department of Cardiology, Faculty of Medicine, Yuzuncu Yil University Van, Van, Turkey.

Yaojun Zhang (Y)

Department of Cardiology, Xuzhou Third People's Hospital, Xuzhou, China.

Pieter Kitslaar (P)

Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Medis Medical Imaging Systems, Leiden, the Netherlands.

Alexander Broersen (A)

Medis Medical Imaging Systems, Leiden, the Netherlands.

Johan H C Reiber (JHC)

Division of Image Processing, Department of Radiology, Leiden University Medical Center, Leiden, the Netherlands.
Medis Medical Imaging Systems, Leiden, the Netherlands.

Jouke Dijkstra (J)

Medis Medical Imaging Systems, Leiden, the Netherlands.

Patrick W Serruys (PW)

Faculty of Medicine, National Heart & Lung Institute, Imperial College London, London, United Kingdom.
Department of Cardiology, University of Galway, Galway, Ireland.

James C Moon (JC)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Institute of Cardiovascular Sciences, University College London, London, United Kingdom.

Andreas Baumbach (A)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Ryo Torii (R)

Department of Mechanical Engineering, University College London, London, United Kingdom.

Francesca Pugliese (F)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Christos V Bourantas (CV)

Department of Cardiology, Barts Heart Centre, Barts Health NHS Trust, London, United Kingdom.
Centre for Cardiovascular Medicine and Devices, William Harvey Research Institute, Queen Mary University of London, London, United Kingdom.

Classifications MeSH